DV
Dividend Vision

TAK — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TAK)

TAK pays a 3.89% distribution rate, semi-annual. Its Distribution Safety Score™ is 83 (Safe), giving a Safety-Adjusted Yield of 3.23%. Total return is 53.0% over the past 18.4 years, 678.7 points behind SPY at 731.7%. Its deepest 1-year drawdown was 19.9%.

Takeda Pharmaceutical Company Limited is a global pharmaceutical company that researches, develops, manufactures, and markets drugs across gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience, with a portfolio including brands such as Entyvio, Advate, Adcetris, and Vyvanse. The company distributes dividends semi-annually at a moderate current distribution rate. Takeda appeals to income-focused investors seeking exposure to established pharmaceutical operations with regular cash returns.

TAK key facts

Distribution Safety Score™
83 · Safe
Safety-Adjusted Yield
3.23%
Asset type
Stock
Asset class
Equity
Inception date
03/06/2008
Distribution rate
3.89%
Distribution frequency
Semi-Annual
Trailing yield
3.52%
5-year average yield
4.53
Last close
$17.63
Market cap
$56,301,453,312
Average volume
3137300.0
Last dividend
$0.2984
Ex-dividend date
03/31/2026
Beta
0.096
Payout ratio
0.8003
P/E ratio
42.2432
Forward P/E
10.7296
EPS
$-0.33